Tagged with Association,

Taiwan Johnsee Lee, chairman of Taiwan Bio Industry Organization, gives an update on the major developments of the country’s biotech environment over recent years, speaking about its new areas of focus, unique strengths, and the remaining amendments necessary to realize the industry’s global ambition. Lee also discusses the organization’s upcoming event…

Egypt Ashraf Elkhouly, executive director of the Egyptian Society for Pharmaceutical Research, discusses how recent healthcare reforms will help to attract more investment to Egypt and the importance of public-private partnerships for improving the country’s healthcare system.   In collaboration with the government, we started to look into possibilities on how…

Korea Myung-Kyu Lee, vice president of the Korea Cosmetic Association, explains how the association helps its member companies both at home and abroad, breaks down the implications of new local and international regulations and explains how the association is adapting to new trends such as customized cosmetic. Lee also points out…

Egypt Marwa Taher, executive director of the Swiss Egyptian Business Association (SEBA), explains how the association is promoting trade relations between the two countries. She also highlights initiatives of both SEBA and Swiss companies to improve healthcare and the wellbeing of Egyptian citizens.   There is strong initiative from both countries…

Spain Javier Urzay, deputy director of Farmaindustria, gives an overview of the growth of the pharmaceutical sector in Spain and the challenges to find a balance between rewarding innovation and sustainability. Moreover, he talks about the development of clinical trials in Spain and the currently discussed new collaboration agreement with the…

China Adam Dunnett, secretary general of the European Union Chamber of Commerce in China (European Chamber) outlines the organization’s three key roles of advocacy, providing business intelligence and strengthening the European business community. He also details an extraordinarily productive past six months – during which the European Chamber held meetings with…

China Pierre Faury, co-President of the French Healthcare Alliance in China as well as vice-President of Sanofi China in charge of Commercial Excellence, shares the mandate of the French Healthcare Alliance and its objective to bring together French companies in China, in collaboration with the French Embassy, to support the development…

Spain Daniel-Anibal Garcia Diego, president of the Spanish Haemophilia Federation (FEDHEMO), discusses the current situation of haemophilia treatment and healthcare coverage in Spain, as well as the unique challenges created by the autonomous regions of the country. He also gives insight into FEDHEMO’s ongoing initiatives and future objectives.   Spain is…

France Guy Maugis, president of the Franco-German Chamber of Commerce and Industry, explains the impact of the Macron government on the attractiveness of France as well as the importance of a strong relationship between Germany and France in times of political uncertainty. He also highlights the role of the chamber in…

Spain Maria Begona Barragan Garcia, president of GEPAC – the Spanish Group of Patients with Cancer – discusses the necessity of the group and its role in Spain’s healthcare system, in addition to how the voice of the patients is now stronger than ever.   GEPAC represents 88 different cancer organizations…

Spain Miguel Valdés, director of Fedifar, the Spanish wholesaler federation, highlights the challenges impacting the local wholesaler network and the unique nature of Spanish wholesaler ecosystem, with the majority of players being cooperative-owned pharmacies. Furthermore, he sends a message about the long-term sustainability of the industry and what must be done…

China Kang Wei, managing director for the R&D-based Pharmaceutical Association Committee (RDPAC) under the China Association of Enterprises with Foreign Investment, shares her priorities for RDPAC in the next few years, her members’ contribution to the Chinese healthcare environment and the national Healthy China 2030 strategy, as well as the importance…